WCG acquires endpoint adjudication and data monitoring firm

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/shironosov)
(Image: Getty/shironosov)
WCG is expanding its Clinical Services Division to include endpoint adjudication and data monitoring services with the acquisition of ACI Clinical.

ACI Clinical’s global network includes more than 500 medical, statistical, and safety experts.

Following the acquisition – terms of which were not disclosed – ACI Clinical will continue to operate as an independent service organization within WCG’s Clinical Services Division.

“Together with WCG, we will work with clinical trial sponsors, academic experts and regulatory agencies to enhance trial integrity, reduce variation in important clinical trial events and ultimately mitigate risk and enhance patient safety in clinical trials,”​ said Jonathan Seltzer, MD, MBA, MA, FACC, president and CEO of ACI Clinical.

WCG has made several acquisitions over the last year​, in areas such as patient recruitment​, electronic consent​ (eConsent), and pharmacovigilance​. 

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars